Navigation Links
Multiple malaria infection inhibits spread of parasite

People who are frequently infected with malaria parasites can develop immunity against the gametocyte, the infectious stage. This immunity inhibits the spread of the parasite. Dutch researcher Mike van der Kolk discovered this during his research into malaria transmission under the inhabitants of Cameroon, Senegal and Indonesia. After just a few infections, people can develop immunity that inhibits transmission.

Malaria is not caused by a mosquito but by a parasite in the mosquito. The malaria parasite needs the mosquito to reproduce and spread. The gametocyte is the developmental stage of the parasite that can be transmitted from people to the mosquito. In the mosquito's stomach the gametes are released and fertilisation takes place. The parasite develops further until the final stage (the sporozoite) in the salivary gland. The sporozoite can be transmitted with the saliva to a person if he/she is bitten by this mosquito. There the parasite reproduces rapidly and the person becomes ill.

Immunity

People who live in areas where malaria is prevalent, can develop a natural immunity that stops the development of the parasite in the mosquito. This prevents the parasite from spreading further. The presence of this immunity, the so-called transmission-reducing activity, is determined using a laboratory test. Van der Kolk discovered that people who are often infected with malaria could quickly acquire this immunity. He also found that people with higher numbers of gametocytes are more frequently immune.

Infectious bites

Each year more than 200 million people develop malaria. More than one million people die from malaria each year. In Cameroon, the researchers recorded how often people were bitten by a mosquito that carried malaria parasites. They also examined the number of transmittable parasites in the blood of infected persons. In a neighbourhood of the capital Yaoundé, 34 infectious bites per person per yea r were found to occur. The number of gametocytes per person was season and age dependent. Children were found to be by far the most important source of malaria transmission in the area. In the village Koundou, the number of infectious bites was about five times as high as in the capital. There previous research had revealed 177 infectious bites.

Test

The existing laboratory test for malaria immunity did not yet work optimally. Therefore the researchers first modified this method before starting the research on immunity. With the improved test, the researchers studied how people not previously exposed to malaria become infected or immune. Migrants in the province of Papua in Indonesia, who had not previously been exposed to malaria were investigated for this purpose. Malaria is highly prevalent in Papua. After just one to four malaria infections the immunity against the infectious gametocytes increased. Immunity therefore develops quickly after exposure to an infection. The researchers expect that the modified methods will make it possible to carry out more detailed studies into the development and maintenance of immunity within the population.


'"/>

Source:Netherlands Organization for Scientific Research


Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Multiple Campylobacter Genomes Sequenced
3. Gene Signatures Predict Interferon Response For Multiple Sclerosis Patients
4. Multiple-drug resistant gene expression pattern predicts treatment outcome for pediatric leukemia
5. OHSU researchers discover potential mechanism to repair brain damage linked to Multiple Sclerosis
6. Multiple genes permit closely related fish species to mix and match their color vision
7. Scientists reveal molecular secrets of the malaria parasite
8. Simple drug has the potential to save many lives threatened by malaria
9. Molecular models advance the fight against malaria
10. Reducing malarial transmission in Africa
11. Sickle cell and protection against malaria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com , ... published the overview results from the Q1 wave of ... recent wave was consumers, receptivity to a program where ... with a health insurance company. "We were ... share," says Michael LaColla , CEO of Troubadour ...
(Date:4/26/2016)... LONDON , April 26, 2016 /PRNewswire/ ... Systems, a product subsidiary of Infosys (NYSE: ... partnership to integrate the Onegini mobile security platform ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration ... security to access and transact across channels. Using ...
(Date:4/14/2016)... 2016 BioCatch ™, the ... announced the appointment of Eyal Goldwerger as ... Goldwerger,s leadership appointment comes at a time of ... deployment of its platform at several of the world,s ... discerns unique cognitive and physiological factors, is a winner ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... CLEVELAND , June 27, 2016  Global ... average 4.6 percent through 2020 to $7.2 billion.  ... (food and beverages, cleaning products, biofuel production, animal ... and biotechnology, diagnostics, and biocatalysts). Food and beverages ... gains driven by increasing consumption of products containing ...
(Date:6/27/2016)... , ... June 27, 2016 , ... ... bring innovative medical technologies, services and solutions to the healthcare market. The company's ... of various distribution, manufacturing, sales and marketing strategies that are necessary to help ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
Breaking Biology Technology: